Autism genetics: Emerging data from genome-wide copynumber and single nucleotide polymorphism scans

Expert Review of Molecular Diagnostics

Volumn 9, Issue 8, 2009, Pages 795-803

  Weiss, Lauren A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Array comparative genomic hybridization; Autism; Copy number variant; Genetics; Genome wide association study

Indexed keywords

METHYL CPG BINDING PROTEIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUBERIN;

AHI1 GENE; ALLELE; ATTENTION DEFICIT DISORDER; AUTISM; CACNA1C GENE; CHROMOSOME 15Q; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CNTNAP2 GENE; COMPARATIVE GENOMIC HYBRIDIZATION; DHCR7 GENE; DIGEORGE SYNDROME; EPILEPSY; FMR1 GENE; GENE; GENE LOCUS; GENE NUMBER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; HAPPY PUPPET SYNDROME; HUMAN; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NF1 GENE; NLGN3 GENE; NLGN4 GENE; NRXN1 GENE; PHENOTYPE; PRADER WILLI SYNDROME; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SMITH MAGENIS SYNDROME; WILLIAMS BEUREN SYNDROME;

AUTISTIC DISORDER; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 70449629672     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.09.59     Document Type: Review

References (64)

1. Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 12(1), 2-22 (2007). • Reviews the evidence for heritability of autism.
2. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 9(5), 341-355 (2008). •• Reviews linkage and candidate gene studies of autism.
3. Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum. Mol. Genet. 18(R1), R1-R8 (2009). • Reviews the contribution of copy number variants (CNVs) to gene expression and disease.
4. Ledbetter DH. Cytogenetic technology - genotype and phenotype. N. Engl. J. Med. 359(16), 1728-1730 (2008).
5. Sebat J, Lakshmi B, Malhotra D et al. Strong association of de novo copy number mutations with autism. Science 316(5823), 445-449 (2007). •• First suggested a major role for CNVs in autism.
6. Szatmari P, Paterson AD, Zwaigenbaum L et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39(3), 319-328 (2007).
7. Feng J, Schroer R, Yan J et al. High frequency of neurexin 1b signal peptide structural variants in patients with autism. Neurosci. Lett. 409(1), 10-13 (2006). (Pubitemid 44585112)
8. Yan J, Noltner K, Feng J et al. Neurexin 1α structural variants associated with autism. Neurosci. Lett. 438(3), 368-370 (2008).
9. Need AC, Ge D, Weale ME et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 5(2), e1000373 (2009).
10. Rujescu D, Ingason A, Cichon S et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 18(5), 988-996 (2009).
11. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am. J. Hum. Genet. 83(4), 504-510 (2008).
12. Kirov G, Gumus D, Chen W et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 17(3), 458-465 (2008).
13. Kim HG, Kishikawa S, Higgins AW et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 82(1), 199-207 (2008). (Pubitemid 351735950)
14. Zahir FR, Baross A, Delaney AD et al. A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1α. J. Med. Genet. 45(4), 239-243 (2008).
15. Morrow EM, Yoo SY, Flavell SW et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321(5886), 218-223 (2008).
16. Weiss LA, Shen Y, Korn JM et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358(7), 667-675 (2008). •• Identified first specific CNV locus by genome-wide screening to be associated with autism; also indicates this CNV has variable expressivity and can lead to other developmental and psychiatric disorders.
17. Kumar RA, KaraMohamed S, Sudi J et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17(4), 628-638 (2008).
18. Marshall CR, Noor A, Vincent JB et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82(2), 477-488 (2008).
19. Sharp AJ, Selzer RR, Veltman JA et al. Characterization of a recurrent 15q24 microdeletion syndrome. Hum. Mol. Genet. 16(5), 567-572 (2007).
20. Durand CM, Betancur C, Boeckers TM et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39(1), 25-27 (2007). (Pubitemid 46026497)
21. Phelan MC. Deletion 22q13.3 syndrome. Orphanet. J. Rare Dis. 3, 14 (2008).
22. Moessner R, Marshall CR, Sutcliffe JS et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81(6), 1289-1297 (2007). (Pubitemid 350211458)
23. Gauthier J, Spiegelman D, Piton A et al. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B(3), 421-424 (2009).
24. Sharp AJ, Mefford HC, Li K et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet. 40(3), 322-328 (2008). (Pubitemid 351311774)
25. Pagnamenta AT, Wing K, Akha ES et al. A 15q13.3 microdeletion segregating with autism. Eur. J. Hum. Genet. 17(5), 687-692 (2009).
26. Ben-Shachar S, Lanpher B, German JR et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J. Med. Genet. 46(6), 382-388 (2009).
27. Miller DT, Shen Y, Weiss LA et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J. Med. Genet. 46(4), 242-248 (2009).
28. Helbig I, Mefford HC, Sharp AJ et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat. Genet. 41(2), 160-162 (2009).
29. Stefansson H, Rujescu D, Cichon S et al. Large recurrent microdeletions associated with schizophrenia. Nature 455(7210), 232-236 (2008).
30. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210), 237-241 (2008).
31. van Bon BW, Mefford HC, Menten B et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from nonpathogenic to a severe outcome. J. Med. Genet. 46, 511-523 (2009).
32. Cusco I, Medrano A, Gener B et al. Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. Hum. Mol. Genet. 18(10), 1795 - 1804 (2009).
33. Brunetti-Pierri N, Berg JS, Scaglia F et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat. Genet. 40(12), 1466-1471 (2008).
34. Mefford HC, Sharp AJ, Baker C et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 359(16), 1685-1699 (2008).
35. Glessner JT, Wang K, Cai G et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459(7246), 569-573 (2009).
36. Weiss LA, Arking DE; Gene Discovery Project of Johns Hopkins and the Autism Consortium. Genome-wide linkage and association scan reveals novel loci for autism. Nature 461, 802-808 (2009). • Large genome-wide association study(GWAS) for autism.
37. Wang K, Zhang H, Ma D et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459(7246), 528-533 (2009). • Large GWAS for autism.
38. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 30(4), 763-773 (2009).
39. Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev. Disabil. Res. Rev. 14(1), 3-10 (2008).
40. Bijlsma EK, Gijsbers AC, Schuurs- Hoeijmakers JH et al. Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur. J. Med. Genet. 52(2-3), 77-87 (2009).
41. Meechan DW, Maynard TM, Gopalakrishna D, Wu Y, LaMantia AS. When half is not enough: gene expression and dosage in the 22q11 deletion syndrome. Gene Expr. 13(6), 299-310 (2007). (Pubitemid 47289403)
42. Jamain S, Quach H, Betancur C et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34(1), 27-29 (2003).
43. Lawson-Yuen A, Saldivar JS, Sommer S, Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur. J. Hum. Genet. 16(5), 614-618 (2008).
44. Ferreira MA, O'Donovan MC, Meng YA et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 40(9), 1056-1058 (2008).
45. Casamassima F, Huang J, Fava M et al. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. DOI: 10.1002/ ajmg.b.30962 (2009) (Epub ahead of print).
46. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum. Mol. Genet. 17(R2), R116-R121 (2008). • Reviews emerging lessons from GWAS in autoimmune disease, suggesting shared pathways.
47. Baranzini SE, Galwey NW, Wang J et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet. 18(11), 2078-2090 (2009).
48. Purcell SM, Wray NR, Stone JL et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256), 748-752 (2009). • Schizophrenia GWAS suggesting genetic architecture includes substantial common polygenic component.
49. Cichon S, Craddock N, Daly M et al. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am. J. Psychiatry 166(5), 540-556 (2009).
50. Psychiatric GWAS Consortium Steering Committee. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol. Psychiatry 14(1), 10-17 (2009).
51. Adolphs R, Spezio ML, Parlier M, Piven J. Distinct face-processing strategies in parents of autistic children. Curr. Biol. 18(14), 1090-1093 (2008).
52. Constantino JN, Todd RD. Intergenerational transmission of subthreshold autistic traits in the general population. Biol. Psychiatry 57(6), 655-660 (2005).
53. Constantino JN, Lajonchere C, Lutz M et al. Autistic social impairment in the siblings of children with pervasive developmental disorders. Am. J. Psychiatry 163(2), 294-296 (2006). (Pubitemid 44480850)
54. Dawson G, Webb SJ, Wijsman E et al. Neurocognitive and electrophysiological evidence of altered face processing in parents of children with autism: implications for a model of abnormal development of social brain circuitry in autism. Dev. Psychopathol. 17(3), 679-697 (2005).
55. Pickles A, Starr E, Kazak S et al. Variable expression of the autism broader phenotype: findings from extended pedigrees. J. Child. Psychol. Psychiatry 41(4), 491-502 (2000). (Pubitemid 30311527)
56. Dalton KM, Nacewicz BM, Alexander AL, Davidson RJ. Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism. Biol. Psychiatry 61(4), 512-520 (2007).
57. Silverman J, Smith C, Schmeidler J et al. Symptom domains in autism and related conditions: evidence for familiality. Am. J. Med. Genet. B Neuropsychiatr. Genet. 114, 64-73 (2002).
58. Piven J, Palmer P, Landa R, Santangelo S, Jacobi D, Childress D. Personality and language characteristics in parents from multiple-incidence autism families. Am. J. Med. Genet. 74(4), 398-411 (1997). (Pubitemid 27349377)
59. Kuperman S, Beeghly JH, Burns TL, Tsai LY. Serotonin relationships of autistic probands and their first-degree relatives. J. Am. Acad. Child Psychiatry 24, 186-190 (1985). (Pubitemid 15100198)
60. Abramson RK, Wright HH, Carpenter R et al. Elevated blood serotonin in autistic probands and their first-degree relatives. J. Autism Dev. Disord. 19, 397-407 (1989). (Pubitemid 19233511)
61. Cook EH, Leventhal BL, Heller W, Metz J, Wainwright M, Freedman DX. Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J. Neuropsychiatry Clin. Neurosci. 2, 268-274 (1990). (Pubitemid 20312481)
62. Cook EH Jr, Charak DA, Arida J, Spohn JA, Roizen NJ, Leventhal BL. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res. 52(1), 25-33 (1994).
63. Leventhal BL, Cook EH Jr, Morford M, Ravitz A, Freedman DX. Relationships of whole blood serotonin and plasma norepinephrine within families. J. Autism Dev. Disord. 20(4), 499-511 (1990).
64. Piven J, Chase GA, Landa R et al. Psychiatric disorders in the parents of autistic individuals. J. Am. Acad. Child Adolesc. Psychiatry 30(3), 471-478 (1991).